Is a patient program really a medicine advertisement? And why couldn’t a pharmaceutical company organise it?
A draft amendment to the Advertising Regulation Act has recently been published and is now due to be discussed by the Government and Parliament. It proposes a number of changes, including in the area of advertising of medicinal products. The attentive reader will be in for many surprises when readin